Cargando…

Controversies in the Treatment of Classical Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a B-cell-derived malignancy that mostly affects young adults. Pathologically, HL is divided into classical HL (cHL) and the rare entity of nodular lymphocyte-predominant HL. Classical HL is characterized by few malignant cells termed Hodgkin and Reed–Sternberg cells embedded...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichenauer, Dennis A., André, Marc, Johnson, Peter, Fossa, Alexander, Casasnovas, Olivier, Engert, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Controversy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407792/ https://www.ncbi.nlm.nih.gov/pubmed/30887012 http://dx.doi.org/10.1097/HS9.0000000000000149

Ejemplares similares

Controversies in the Treatment of Follicular Lymphoma
por: Hübel, Kai, et al.
Publicado: (2020)

Controversies in the Treatment of Peripheral T-cell Lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2020)

Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma
por: Pirosa, Maria Cristina, et al.
Publicado: (2022)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Current controversies: Null hypothesis significance testing
por: Sedgwick, Philip M., et al.
Publicado: (2022)

Expanded use of rituximab in the management of non-Hodgkin lymphoma
por: Eichenauer, Dennis A, et al.
Publicado: (2009)

Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope
por: Brignole, Michele, et al.
Publicado: (2023)

Controversy: Is There a Role for Adjuvants in the Management of Male Pattern Hair Loss?
por: Rajput, Rajendrasingh J
Publicado: (2010)

Controversies in implementing non‐invasive prenatal testing in a public antenatal care program
por: Salvesen, Kjell Åsmund Blix, et al.
Publicado: (2022)

Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients
por: Momotow, Jesko, et al.
Publicado: (2021)

Introducing the HemaSphere Controversies Series
por: Eichenauer, Dennis A., et al.
Publicado: (2019)

Therapy-Related Myeloid Neoplasms in Patients Treated for Hodgkin Lymphoma
por: Eichenauer, D.A., et al.
Publicado: (2011)

Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014
por: Junior, Gilberto de Lima Lopes
Publicado: (2014)

Current controversies and irresolvable disagreement: the case of Vincent Lambert and the role of ‘dissensus’
por: Wilkinson, Dominic, et al.
Publicado: (2019)

Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
por: Gill, Sharlene
Publicado: (2014)

Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox
por: Sharpe, Michael, et al.
Publicado: (2019)

More Ethics of Controversy
por: Macdonald, Isabel
Publicado: (1919)

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
por: Damaschin, Carla, et al.
Publicado: (2021)

Treatment of apical vaginal prolapse with minimal mesh repair (Uphold): patient‐reported long‐term outcomes and mesh‐related complications
por: Munch, Anne, et al.
Publicado: (2022)

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta‐analysis
por: Eriksen, Dina Overgaard, et al.
Publicado: (2022)

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
por: Borchmann, Peter, et al.
Publicado: (2022)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Post-treatment parenthood in Hodgkin's lymphoma survivors
por: Kiserud, C E, et al.
Publicado: (2007)

Minimally Invasive Vitreoretinal Surgery: Is Sutureless Vitrectomy the Future of Vitreoretinal Surgery?
Publicado: (2011)

Botulinum Toxin Deaths: What is the Fact?
por: Omprakash HM,, et al.
Publicado: (2008)

Stability in Vitiligo: Why Such a Hullabaloo?
por: Gupta, Somesh
Publicado: (2009)

Stability in Vitiligo? What's that?
por: Lahiri, Koushik
Publicado: (2009)

Does Topical Tretinoin Used for Chemoprevention Cause Increased Mortality?
por: Sangolli, Prabhakar M
Publicado: (2009)

Radial Optic Neurotomy for Central Retinal Vein Occlusion
por: Ramezani, Ali-Reza
Publicado: (2009)

Resistance to apoptosis should not be taken as a hallmark of cancer
por: Wang, Rui-An, et al.
Publicado: (2014)

Are Antibody Panels Under‐Utilized in Movement Disorders Diagnosis? Yes
por: Balint, Bettina
Publicado: (2021)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

New PET technologies – embracing progress and pushing the limits
por: Aide, Nicolas, et al.
Publicado: (2021)

Endoscopic biliary drainage for malignant distal biliary obstruction: Which is better – endoscopic retrograde cholangiopancreatography or endoscopic ultrasound?
por: Bang, Ji Young, et al.
Publicado: (2021)

Term breech presentation—Intended cesarean section versus intended vaginal delivery—A systematic review and meta‐analysis
por: Wängberg Nordborg, Julia, et al.
Publicado: (2022)

Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia
por: Hammer, Anne, et al.
Publicado: (2022)

Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus
por: Grønvall, Lina, et al.
Publicado: (2021)

“I feel reassured, but there is no guarantee.” How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study
por: Hansen, Joan, et al.
Publicado: (2022)

PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?
por: Rossi, Cédric, et al.
Publicado: (2019)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
por: Eichenauer, Dennis A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jae0kli5hc8p2n8k5fkpjtsgdc